Home > Balance Sheet > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹7.31 Cr₹10 Cr--₹0.83 Cr

What is the latest Capital Work in Progress ratio of BAFNA PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of BAFNA PHARMACEUTICALS is ₹7.31 Cr based on Mar2025 Standalone results.
Year Capital Work in Progress
Mar2025₹7.31 Cr
Mar2024₹10 Cr
Mar2023-
Mar2022-
Mar2021₹0.83 Cr

How is Capital Work in Progress of BAFNA PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2025 ₹7.31 Cr
-30.33
Mar2024 ₹10 Cr
0
Mar2023 -
0
Mar2022 -
-100.00
Mar2021 ₹0.83 Cr -

Compare Capital Work in Progress of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹268.6 Cr 0.4% 6.6% 50.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,713.0 Cr -1.4% -3.2% -0.5% Stock Analytics
DIVIS LABORATORIES ₹156,811.0 Cr -1.9% -8.7% 1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹139,052.0 Cr -3.5% -6.6% 30.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,927.0 Cr -4% -8.3% 6.3% Stock Analytics
CIPLA ₹96,602.7 Cr -1.9% -11.9% -19% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

0.4%

6.6%

50.5%

SENSEX

0.6%

-11.1%

-6.2%


You may also like the below Video Courses